Veracyte, Genzyme Co-marketing Thyroid Dx Tool
January 20, 2012
Veracyte, Genzyme Co-marketing Thyroid Dx Tool
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- MDx/CDx Focus: Positive Data for Trastuzumab Emtansine; Veracyte Gets NY OK for Afirma Thyroid Dx
August 29, 2012 / Pharmacogenomics Reporter - UnitedHealthcare Starting Coverage of Veractye's Thyroid Cancer MDx
March 8, 2013 / GenomeWeb Daily News - PROOF, IO Informatics to Develop App Aimed at Heart, Lung, and Kidney Disease
September 11, 2012 / GenomeWeb Daily News - Veracyte's Thyroid Cancer MDx Gets New York State OK
August 29, 2012 / GenomeWeb Daily News - Prospective Validation Confirms Sensitivity of Veracyte's Gene Expression Test for Thyroid Nodule Risk
June 27, 2012 / Pharmacogenomics Reporter